Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. (B1851065)
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Kontakter og lokationer
Studiesteder
-
-
-
Alexandroupoli, Grækenland, 68100
- General University Hospital of Alexandroupoli
-
Athens, Grækenland, 11527
- General Chest Diseases Hospital "Sotiria"/ 7th Department of Pulmonary Medicine
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 12Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 1St Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 2Nd Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 5Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 6Th Pneumonology Clinic
-
Athens, Grækenland, 11527
- General Hospital of Athens "Sotiria"/ 8Th Pneumonology Clinic
-
Athens, Grækenland, 15123
- Diagnostic Therapeutic Center of Athens Ygeia
-
Athens, Grækenland, 15126
- General Hospital Athens "Sismanoglio"/ 1St Pneumonology Clinic
-
Athens, Grækenland, 15126
- General Hospital of Athens "Sismanoglio" / 3Rd Pneumonology Department
-
Athens, Grækenland, 15126
- General Hospital of Athens "Sismanoglio"/ 2Nd Pneumonology Clinic
-
Athens, Grækenland, 15127
- General Hospital Mellision "Amalia Fleming"/ Pneumonology Clinic
-
Athens, Grækenland, 15127
- General Hospital Mellision "Amalia Fleming"/2nd Internal Medicine Department
-
Athens, Grækenland, 15227
- Sotiria Hospital, Intensive Care Unit
-
Athnens, Grækenland
- General University Hospital "Attikgeneral University Hospital "Attikon"/ 4Th University Internal Med
-
Kavala, Grækenland, 65201
- General Hospital of Kavala/ A Pneumonological Clinic
-
Kavala, Grækenland, 65201
- General Hospital of Kavala/ b Pneumonological & Tubeculosis Department
-
Larissa, Grækenland, 41 110
- University General Hospial of Larissa, Pneumonology Department
-
-
Attiki
-
Athens, Attiki, Grækenland
- General Hospital of Athens "Evangelismos" / Pneumonology Department
-
-
Evros
-
Alexandroupoli, Evros, Grækenland, 68100
- University Hospital of Alexandroupolis
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients who agreed to participate in the study and agreed to sign an ICD.
- Patients had to be ≥18 years of age (adults)
- Patients had to present or had been referred to a participating healthcare facility with suspected pneumonia based on the physician's assessment (including but not limited to specific signs and symptoms described in Section 9.3 of the protocol)
- Patients must have had a posteroanterior or anteroposterior chest X-ray showing an infiltrate (if previous films were not available) or a new infiltrate (if recent film was available)
- Patients had to be tested positive for the Binax NOW® assay (required post Protocol Amendment 2)
Exclusion Criteria:
- Patients who did not sign an ICD.
- Any patient who developed signs and symptoms of pneumonia after being hospitalized for ≥48 hours
- Any patient who was transferred to a study healthcare facility after already being hospitalized for ≥48 hours at another healthcare facility
- Patients who did not have a chest X-ray performed
- Patients who did not have the Binax NOW® assay performed
- Patients with negative results for the Binax NOW® assay (required post Protocol Amendment 2)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kun etui
- Tidsperspektiver: Fremadrettet
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Group one
Adults ≥18 years of age with chest X-ray confirmed CAP
|
This Is A Non Interventional Study
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The frequency of serotypes 4,6B,9V,14,18C,19F,23F,1,3,5,6A,7F and 19A from chest X-ray confirmed pCAP patients (post amendment2 with positive Binax NOW® only) who presented in the emergency departments of 15 hospitals in Greece during 1
Tidsramme: One year
|
One year
|
|
calendar year.
Tidsramme: One year
|
One year
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Susceptibility, resistance or partial resistance Streptococcus pneumoniae clinical isolates obtained from study adult CAP patients.
Tidsramme: One year
|
One year
|
|
The frequency of the 4, 6B, 9V, 14, 18C, 19F, 23F, 1, 3, 5, 6A, 7F, 19A serotypes (based on Luminex assay) of study patients immunized and not immunized with PPV.
Tidsramme: One year
|
One year
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- B1851065
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .